Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high
Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high ORLANDO ? The price of generic imatinib has decreased substantially in the United States over the past 2 years, according to a speaker at ASH Annual Meeting and Exposition. The decline comes after steep increases in…
WHAT IS PHARMA PATENTING: A JUDICIAL APPROACH
WHAT IS PHARMA PATENTING: A JUDICIAL APPROACH FROM {TAJ PHARMA INDIA} BRAND INFRINGEMENT ?Affluent societies are spending vast sums of money understandably on the search for new products and processes to alleviate suffering and to prolong life. In the process, drug manufactures have become a powerful industry. My idea of…